Business Description
August, 2016 -
Takeda has confirmed its proposal to close its Cambridge Science Park facility after nine years spin off key programmes and capabilities to a Takeda-funded biotech, and transferring some capabilities to other locations within Takeda. Its London site will shift its focus from global to European-level activities, with fewer functions based at this location.
In the UK, Takeda has a head office in High Wycombe.
“Takeda Pharmaceutical Company Limited is Japan's largest pharmaceutical company, and is the world-leader in oral diabetes medicines.
TCB and its subsidiary TSP, have established world-class target identification and validation capabilities. Together they have developed a promising pipeline of novel drug discovery targets and compounds in such key areas of unmet medical need as CNS disorders, endocrinology and metabolic-related diseases."
